埃博拉病毒IgM抗体检测试剂盒

美国NovaBios埃博拉病毒IgM抗体检测试剂盒

广州健仑生物科技有限公司

本司长期供应埃博拉病毒检测试剂盒，其主要品牌包括美国NovaBios、广州创仑等CDC使用的进口产品，试剂盒的实验方法包括胶体金方法、ELISA方法、PCR方法等。

欢迎咨询

欢迎咨询2042552662

埃博拉病毒IgM、IgG、ELISA检测试剂、埃博拉快速检测试剂盒、

埃博拉病毒核酸检测试剂盒（荧光探针PCR）

西非工作、旅游埃博拉检测试剂盒

美国CDC使用的埃博拉诊断试剂——美国的NovaBios

美国NovaBios 埃博拉病毒IgM抗体检测试剂盒

【埃博拉简介】

埃博拉（Ebola virus）又译作伊波拉病毒。是一种十分罕见的病毒，1976年在苏丹南部和刚果（金）（旧称扎伊尔）的埃博拉河地区发现它的存在后，引起医学界的广泛关注和重视，“埃博拉”由此而得名。是一个用来称呼一群属于纤维病毒科埃博拉病毒属下数种病毒的通用术语。是一种能引起人类和灵长类动物产生埃博拉出血热的烈性传染病病毒，有很高的死亡率，在50%至90%之间，致死原因主要为中风、心肌梗塞、低血容量休克或多发性器官衰竭。

埃博拉出血热（EBHF）是由一种丝状病毒感染导致的急性出血性、动物源性传染病。1976年，埃博拉出血热在非洲的苏丹和扎伊尔暴发，病死率高达50% ～ 90% 。因该病始发于扎伊尔北部的埃博拉河流，并在该区域严重流行，故命名为埃博拉病毒，其形态学、致病性等与马尔堡病毒相似，但免疫原性有所区别。

【产品介绍】

该产品是世界卫生组织（WHO）*个批准用于埃博拉病毒检测的诊断试剂卡。不需要借助其他实验仪器设备，只需要采取几滴血清、血浆、血液样品，既可以检测，并在15分钟内就可以得知结果是否感染埃博拉病毒。该产品具有灵敏度高、操作方便、实验时间短等特点。

美国NovaBios

比利时人皮奥特1976年与同事共同发现了埃博拉病毒，后来出任埃博拉病毒艾滋病规划署执行主任，现在担任英国伦敦卫生和热带医学院院长。
　　皮奥特7月30日接受媒体采访时说，埃博拉病毒经由“非常亲密的接触”传染给他人。举例说，“如果我与一名埃博拉病毒感染者同乘地铁，相邻而坐，只要他不呕吐在我身上，我就没什么好担心”。
　　在皮奥特看来，即使有埃博拉病毒感染者从西非国家飞往欧洲、美国或非洲其他地区，那些地区暴发埃博拉疫情的可能性仍然不大。
注重卫生防护
　　1976年，27岁的皮奥职于比利时安特卫普一家实验室，收到一份血液样本，其患者在刚果（金）病故。皮奥特与同事从血液样本中分离出一种病毒，后来证实是埃博拉病毒。
　　皮奥特随后前往刚果（金），发现在不少村庄的人感染埃博拉病毒，但患者集中于20岁至30岁的女性，以及曾经参加葬礼的人。经过调查，真相大白：不少孕妇曾就诊于当地同一家诊所，重复使用针头，导致感染病毒；当地人为死者整理仪容时，没有佩戴手套。皮奥特说：“大规模疫情就是这样暴发的，如今发生在西非国家的情形如出一辙。”
加紧测试疫苗
　　无国界医生组织发出警告，西非多国的埃博拉疫情正在恶化，目前依然缺乏应对疫情的整体策略。
　　皮奥特介绍，眼下已有多款针对埃博拉病毒的试验性疫苗和试验性疗法，在动物实验中显现较好疗效，但尚未用于人体试验。
　　他建议英国政府尽快让这些疫苗和疗法进入人体试验阶段，“一旦下一场疫病来临，我们不至于措手不及”。
重要事实
以往被称作埃博拉病毒性出血热的埃博拉病毒病（EVD）可在人间引起严重且往往致命疾病。
病毒通过野生动物传到人，并在人间通过人际间传播蔓延。
埃博拉病毒病平均病死率约为50%。在以往疫情中出现的病死率从25%到90%不等。

美国NovaBios

我司还提供其它进口或国产试剂盒：登革热、疟疾、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

想了解更多的NovaBios产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司
【市场部】    杨永汉

【】 
【腾讯  】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

Belgian Piot In 1976, he worked with colleagues to discover the Ebola virus, and later served as executive director of the Ebola virus and AIDS program, and now serves as dean of the London School of Hygiene and Tropical Medicine.
Pieter said in an interview on July 30 that the Ebola virus is transmitted to others via "very close contact". For example, "if I sit with an Ebola virus infected by the subway, sitting adjacent to him, as long as he does not vomit on me, I have nothing to worry about."
In the case of Piot, even if there are Ebola virus infected from West African countries to Europe, the United States or other parts of Africa, those areas of the outbreak of Ebola epidemic is still unlikely.
Focus on health protection
In 1976, the 27-year-old Piot worked at a laboratory in Antwerp, Belgium, to receive a blood sample, whose patient died in the Congo (DRC). Piote and colleagues isolated a virus from the blood sample, which was later confirmed to be an Ebola virus.
Piote then went to Congo (DRC) and found that people in many villages were infected with Ebola virus, but the patients were concentrated in women aged 20 to 30 years, and those who had attended the funeral. After investigation, the truth: many pregnant women have been treated in the same local clinic, re-use of the needle, leading to infection with the virus; the locals for the deceased when finishing, did not wear gloves. "The outbreak of mass outbreaks is exactly the same in the West African countries," he said.
Step up the test vaccine
Médecins Sans Frontières (MSF) has warned that the Ebola epidemic in West African countries is deteriorating and there is still a lack of an overall strategy to deal with the epidemic.
Piot has introduced a number of experimental vaccines and experimental therapies for Ebola virus, which have a good effect in animal experiments, but have not been used in human trials.
He suggested that the British government as soon as possible so that these vaccines and therapies into the human trial stage, "once the next disease comes, we will not be caught off guard."
Important facts
Ebola virus disease (EVD), formerly known as Ebola virus haemorrhagic fever, can cause severe and often fatal disease in humans.
The virus spread through the wild animals, and spread through the interpersonal spread in the world.
Ebola virus disease average mortality rate of about 50%. The mortality rate in the previous epidemic varies from 25% to 90%.